The RCVS Disciplinary Committee has suspended a Co. Tyrone veterinary surgeon from the Register for ten months, having found him guilty of serious professional misconduct relating to three convictions for contravening animal export regulations.
Whilst working as an Authorised Veterinary Inspector in Castlederg for the Department of Agriculture and Rural Development (DARD), William Manson had falsely certified that he had inspected three consignments of sheep presented for assembly at Plumbridge Export Assembly Centre on 16 and 23 August 2009. At this week's two-day hearing, Mr Manson admitted that the convictions he had received at the Strabane Magistrates Court on 26 November 2010 made him unfit to practise veterinary surgery, but said in mitigation that he had examined the sheep nearby at Landahussy, a site he considered more suitable for a large number of animals.
The Committee was satisfied that Mr Manson believed the Landahussy site to be more suitable for large deliveries; the Committee also was satisfied that he did carry out a visual inspection of the sheep at the Landahussy site on 16 and 23 August 2009. However, the information Mr Manson provided on the three certificates was false and misleading. Mr Manson had also been reminded of the importance of complying with government regulations in a disciplinary case in 2004, following convictions for failing to notify DARD about changes in the number of sheep for which he was claiming a premium. The then Committee dismissed the case, deeming the convictions a result of his "genuine but regrettable oversight".
Speaking on behalf of the Committee, Chairman, Prof Peter Lees said: "Mr Manson's actions in certifying that he had examined the sheep at an approved assembly centre when he had not done so amounted to a serious departure from professional standards. If there had been a disease outbreak on either the Plumbridge or Landahussy site, such actions would have rendered contact tracings unreliable and inaccurate."
In mitigation, the Committee accepted medical evidence and Mr Manson's testimony that he was at that time under exceptional stress. He was working long hours in difficult circumstances without an assistant, and was under considerable personal pressure as a result of his wife's serious illness. It also took into account his age (66), exceptional testimonials produced on his behalf, and the impact on the community he served.
Prof Lees said: "The Committee has concluded that the removal of Mr Manson's name from the Register is neither proportionate nor necessary in the public interest nor to protect the welfare of animals. A proportionate sanction in this case is to suspend Mr Manson's name from the Register for a period of ten months."
Petplan has launched a new system through which veterinary staff at Appointed Representative (AR) practices can activate 4 weeks Immediate Veterinary Cover (IVC) for clients' puppies, kittens and rabbits at www.petplanvet.co.uk.
Petplan says the new system will greatly improve its service to the veterinary industry, enabling same day information transfer, reducing the amount of paperwork and admin for veterinary staff as well as ruling out the chances of paperwork getting lost or delayed in the post.
Simon Masding, Petplan Head of Sales and Partnerships said: "Petplan has the most established cover note scheme in the market and due to the strength of our brand and the products we offer is able to generate more insured clients for practices than any other provider. Our team of Account Executives visit practices across the UK on a daily basis which means we understand the pressures of day-to-day practice life. Our new online IVC service is just one of the innovative ways we try to make things easier for veterinary staff so they can focus on looking after clients and their pets."
For more information about becoming a Petplan AR practice, and Immediate Veterinary Cover, call Petplan's Vetline on 0800 316 8800.
Any practices that activate IVC online at petplanvet.co.uk before 31st July 2012 will be entered into a prize draw to win an iPad.
Animalcare has launched a new broad spectrum fluoroquinolone antimicrobial (Enrofloxacin) which the company says is highly effective in the treatment of a wide range of conditions and easy to inject, with excellent tissue penetration.
Enrocare solution for injection is presented in three strengths: A 25mg/ml (2.5%) injection for dogs, cats and exotic animals including reptiles, small mammals and avian species. The 50mg/ml (5%) injection is licensed for use in cattle, pigs, dogs and cats, whilst the 100mg/ml (10%) injection is licensed for cattle and pigs. In the case of dogs and cats a single daily dose is needed.
Animalcare says it has priced Enrocare competitively. In addition, the range has been launched with three offers: "Buy one get one free on the 50 and 100mg/ml" and "Buy two get one free offer" on the 25mg/ml pack size. These offers will last for four months until the end of September.
In cattle, Enrocare 50mg/ml, given by the subcutaneous route, is licensed for respiratory disease of bacterial or mycoplasmal origin and the 100mg/ml strength is licenced for both respiratory disease and E.coli mastitis (the latter given by slow intravenous injection). According to Animalcare, its low dose volume makes it particularly suitable for the treatment of respiratory disease in calves. In pigs >25kg Enrocare is licensed for the treatment of the respiratory and alimentary tract diseases of bacterial or mycoplasmal origin and multi-factorial diseases such as atrophic rhinitis and enzootic pneumonia.
Tony Liepman, Animalcare Market Manager said: "The recent successful launch of Cephacare flavour raised Animalcare's profile as a supplier of more up-to-date antibiotics and this is our latest addition which offers excellent efficacy at an attractive price."
Pfizer VPS has launched a 'Pre-Sale Scab Treatment Certificate' so that sheep treated for sheep scab and protected against re-infestation beyond their autumn sale date can be formally certified as such.
A choice of two moxidectin-based treatments are eligible for use, one with 28 days and the other 60 days licensed persistency against the scab mite.
Pfizer VPS vet David Bartram explained that following treatment, the sale date must fall within the persistency window: "The idea is that farmers present their certificate at markets on sale day, then auctioneers announce the scab-protected status during their sales patter. Whether this adds to the sale price will be interesting to find out, but it's sure to be seen as a valuable attribute by buyers who won't need to treat for scab when they arrive home."
Details of the certification process are available from SQPs at animal medicine suppliers. The two eligible treatments are CYDECTIN 1% LA and CYDECTIN 2% LA for sheep.
Petplan has announced the finalists for the 2009 Veterinary Awards.
The company says it was inundated with more than 2300 nominations this year and that the public response was 'astonishing', with tales ranging from midnight rescues to simple acts of kindness and this year was no exception.
The finalists for each of the categories are as follows:
Vet of the YearJamie Rushton, Village Vet Hampstead, LondonBen Jones, Ben Jones Veterinary Surgery, Chester, FlintshireMatthew Fry, Quarrington Veterinary Surgery, Sleaford, Lincolnshire
Vet Nurse of the YearCharlotte Maude, Companion Care Veterinary Surgery Chesterfield, Markham, ChesterfieldKaren McQuaid, The Old Golfhouse Veterinary Group, Watton, NorfolkRachel Smith, 608 Veterinary Group, Solihull, West Midlands
Vet Receptionist of the YearYasmin Morowa, Melton Veterinary Surgery, Woodbridge, SuffolkJackie Crampton, Companion Care Veterinary Surgery Chesterfield, Markham, ChesterfieldSara Abbott, Pet Doctors, East Horsley, Surrey
Vet Practice of the YearAshfield House Veterinary Hospital Limited, Long Eaton, NottinghamshireCarrick Veterinary Group CVS (UK) Ltd, Newbold, ChesterfieldSt Clair Veterinary Group, Kirkcaldy, Fife
Simon Wheeler, Petplan's Head of Marketing said he was thrilled by the record number of nominations received:
"This year we are celebrating the tenth anniversary of the Veterinary Awards which were launched so pet owners could thank their practice for the tireless and wonderful work they carry out. We are delighted that the awards, which we often hear referred to as the 'Vet Oscars', are still going strong. This year we have received over 2300 nominations and the quality and standard really challenged the skills of our esteemed judging panel. We would like to wish those short listed every success on the night."
All finalists will be invited to a 'glittering' awards ceremony that will take place on 2nd April at the Burlington Hotel in Birmingham where the winners will be announced.
Culture Change In Healthcare is presented by Simon Fleming, a trauma and orthopaedic registrar who has a special interest in combating bullying, undermining and harassment in human healthcare, and Sally Everitt MRCVS, the ex Head of Scientific Policy at BSAVA.
Simon will discuss the problem of bullying, the fallout from serious cases, and how you can work to eliminate bullying in your practice.
Sally will present the results of a survey carried out by VetSurgeon.org and VetNurse.co.uk in 2017, to investigate the incidence and impact of unpleasant behaviour in veterinary practice.
The webinar is hosted by The Webinar Vet and sponsored by RCVS Mind Matters. It counts as 1hr towards your annual CPD requirement.
Whether or not you think there is any bullying going on at your practice, I strongly urge you to watch this webinar. There can be few things as harmful to an effective practice team as bullying. Everyone needs to be able to spot it and stamp on it quickly.
Register for the webinar here: https://www.thewebinarvet.com/pages/culture-change-healthcare-2/
Feliway Help! comes as a starter pack with a pheromone cartridge which lasts seven days and covers 50m2.
The cartridge is inserted into a diffuser which is plugged into an electrical socket, two days before the stressful event.
Ceva says that 83% of cat owners saw an improvement in their cat’s signs of stress after using Feliway Help!1.
The company adds that the Feliway Help! is particularly useful for clients of those practices which Feliway on the premises, with Feliway helping keep the cat calm at the practice, and Feliway Help! taking over when they return home.
Sarah Heath BVSc PgCertVE DipECAWBM(BM) CCAB FRCVS, an RCVS and EBVS European Veterinary Specialist in Behavioural Medicine and Certified Clinical Animal Behaviourist, said: “Cats can find the veterinary visit challenging and when they go home they can sometimes find it hard to settle.
"Feliway Help! can be very beneficial in easing the transition between home and the practice.
"This can be particularly helpful when cats have had a stay in hospital.”
For more information, visit www.feliway.com/uk, call the Ceva Animal Health head office on 01494 781510 or email cevauk@ceva.com.
Reference
The awards, which which celebrate initiatives that advance the quality of veterinary care and demonstrate a commitment to using an evidence-based approach, will be open for applications until 13th January 2023.
The two new award categories are Antimicrobial Stewardship and Canine Cruciate Outcomes.
The Canine Cruciate Outcome Awards are to recognise and celebrate individuals and teams who are using Quality Improvement initiatives alongside RCVS Knowledge’s Canine Cruciate Registry (CCR) to monitor and improve their canine cruciate surgery outcomes.
Applications are invited by surgeons and teams who are using the CCR.
The Antimicrobial Stewardship Awards, which are divided into farm animal, equine, and companion animal categories, aim to showcase practical examples where individuals and teams are improving responsible antimicrobial prescribing.
In addition, the charity is looking for entries for its existing awards for students and those who have implemented Quality Improvement (QI) techniques.
The Veterinary Evidence Student Awards enables students from around the world to enhance their academic and research skills by writing a Knowledge Summary and submitting it for publication to Veterinary Evidence, RCVS Knowledge's open access, peer-reviewed journal.
The Quality Improvement Awards showcase the implementation of Quality Improvement techniques which drive improvement within the professions.
www.rcvsknowledge.org/awards
The procedure involves introducing a catheter through the jugular, then using fluoroscopy and transoesophageal echocardiography to guide it from the right atrium through to the left side of the heart to relieve abnormal high pressures in the left atrium.
Willows says it is one of only a few centres across Europe equipped to carry out the procedure and that typically, patients who undergo TSP can be discharged from hospital the day after surgery.
Fabio Sarcinella (pictured right), an RCVS and European specialist in small animal cardiology at Willows, said: “Early clinical evaluation of the TSP procedure in humans over the last few years has shown improved quality of life and reduced clinical signs in patients with heart failure.
“The procedure has also been associated with low-risk and a meaningful drop in left atrial pressure of the affected patients.”
Fabio added: “As well as being minimally invasive, the improvement in heart chamber pressures via TSP often allows for a reduction in the dose of water tablets which are used to control the heart failure signs in the lungs.
"Lowering the dose reduces the risk of side effects related to these drugs such as kidney failure.”
Willows says TSP is most commonly used for left atrial decompression in dogs with heart failure and concurrent renal disease or that have advanced heart failure but continue to have symptoms despite optimal medical treatment.
www.willows.uk.net
The researchers say that previous research suggests that approximately 10% of diabetic cats are euthanised at the time of diagnosis, making it a significant cat welfare issue.
However, this figure was largely based on questionnaire-based research from several global locations.
This new study followed the survival of 1,053 cats with confirmed diabetes mellitus under UK primary-care practices in 2019, providing the most up-to-date baseline data on early death among diabetic cats in the UK, as well as examining risk factors for the development of diabetes among UK pet cats.
The study found:
Based on these findings, the researchers encourage veterinarians to more actively discuss diabetes mellitus risk with cat owners, particularly those with Burmilla and Burmese breeds, in the hope that raising awareness of the disease might improve outcomes through earlier diagnosis, and by taking actions that might prevent diabetes mellitus development in the first instance, such as preventing cats becoming obese.
Dr Oliver Waite, Senior Lecturer in Small Animal Medicine at Murdoch University, and primary author of the paper, said: “We hope that this new, large scale epidemiological study, investigating the second most common endocrine disease in cats, will help to highlight current as well as future areas to improve cat welfare.
"This is an exciting time for the management of diabetic cats but more work is still needed!”
Dr Dan O’Neill, Associate Professor in Companion Animal Epidemiology at the RVC, and co-author of the paper, said: “This new VetCompass study shows the value of everyone working in primary care practice sharing their anonymised clinical data to get a better understanding of real-world animal health.
"Awareness of the scale of the diabetes mellitus issue revealed here can empower veterinary professionals to engage in more conversations with owners about diabetes mellitus prevention in predisposed cats.”
The report is the culmination of the work of a joint RCVS and VSC BAME Student Support Working Group, set up to explore key issues in supporting BAME veterinary students during their studies.
The Working Group made a total of 14 recommendations, which included:
Stephanie-Rae Flicker is a recent Royal Veterinary College (RVC) graduate who co-chaired the Working Group alongside Professor Rob Pettitt from the University of Liverpool.
She said: “I hope this encourages and supports our veterinary institutions to actively implement change regarding discrimination faced during studies and placements, nurturing role models and helping affected students develop sense of belonging and community during their studies and beyond.
"Many thanks to all that have contributed to the completion of this Report – we hope the recommendations have a lasting impact, and benefit those both already present and yet to enter our profession."
RCVS/VSC BAME Student Support Working Group Report.
Merial has announced the launch of a new Blippar app designed to educate horse owners about gastric ulcers.
By using the app - which is available free from the App Store for iPhone or Google Play for Android phones - to scan the company's Gastrogard (omeprazole) adverts, posters or website, clients can watch an educational film with one of the UK's leading specialists in equine ulcers, Richard Hepburn BVSc MS(Hons) CertEM(IntMed) DipACVIM(LA) MRCVS, American and RCVS Specialist in Equine Internal Medicine, demonstrating the signs of ulcers and diagnosis via gastroscopy.
Merial's Equine Marketing and Technical Manager Louise Radford MRCVS said: "With 60% of competition horse and 38% of leisure horses & ponies estimated to have gastric ulcers¹,²,³, it's important that horse owners are aware of the signs of this under-diagnosed condition.
"We know that the number of horses diagnosed and treated for ulcers falls significantly short of incidence levels. We hope that this app will help to raise awareness and prompt more horse owners to consult their vet about gastric ulceration."
A separate Blippar app is also available for horse owners that have been prescribed GastroGard. By scanning the pack, clients can view educational video footage on gastric ulcers, find management tips on treatment and prevention, and set a reminder for future risk periods.
For more information, visit: http://www.equinegastriculcers.co.uk, contact your local Merial equine territory specialist or call Merial Customer Support on 0870 6000123.
References
Kruuse UK has announced that it will be launching its new Android telemetric ECG system at BEVA 2011.
The original Televet 100 supports transmission of ECG data to a range of approx 100m (330ft), allowing recording and displaying of real time data only within a confined lunging or riding arena. By linking this system to a mobile network via 3G Android phone and a Windows 7 based tablet PC, the new Televet system overcomes this range limitation.
The new system requires the rider/horse to carry a 3G mobile phone which transmits data over the mobile internet, allowing the veterinary surgeon to display and record real time data on any PC/laptop with internet access or mobile internet connection. This also includes GPS information collected by the phone allowing the ECG, heart rate and velocity of the horse to be displayed in parallel.
The Android Telemetric ECG system is specifically targeted towards veterinary applications in the field of sports horses where extended range is particularly useful, such as endurance riding, three day eventing and racing.
Televet software can now also be integrated in Dicom infrastructures in practice for data capture and recording.
Sarah Stokes, Kruuse Equine Territory Manager said: "the flexibility and simplicity of the system along with immediate access to ECG data of patients will be an invaluable diagnostic tool for UK vets allowing vital support for patients and owners wherever they are."
Visitors to the Kruuse stand at BEVA 2011 will also have the chance to win an Acer ICONI W500 tablet worth £500.
The RCVS has announced a total of £1 million funding to address mental health and wellbeing within the veterinary profession over the next five years.
The RCVS Operational Board has agreed £100K of funding for the first year of the Mind Matters initiative, with a view to a similar amount per year for the subsequent four years.
Additionally, the College says it intends to contribute approximately £500K over the next five years to the Veterinary Surgeons' Health Support Programme (VSHSP). This is a continuation of previous funding, effectively doubling the College's contribution. The VSHSP, independently run by the Veterinary Benevolent Fund, offers a confidential service that aims to combat problems with alcohol, drugs, eating disorders and other addictive and mental health issues. Neil Smith, Mind Matters' Chair said: "I am delighted that we have £500K of new funding over the next five years to dedicate to improving the mental health and wellbeing of the veterinary team, together with the increase to our support for the VSHSP. It shows the College's commitment in this vital area, and is a substantial amount that will really help change lives."
The funding will be reviewed annually as part of the RCVS budgeting process.
Mind Matters activities will fall into five streams:
Mind Matters is supported by a taskforce comprising the Veterinary Benevolent Fund, the British Veterinary Association, the British Veterinary Nursing Association, the Veterinary Practice Management Association, the Veterinary Schools Council, the Veterinary Defence Society, the Society of Practising Veterinary Surgeons and the Association of Veterinary Students.
The National Office of Animal Health Code of Practice Committee has found MSD Animal Health in breach of the NOAH Code on promotion for its advertisment for Equilis Prequenza.
The advert appeared in three separate issues of Veterinary Times (15, 22 and 29 September 2014), on the rear back cover of the 2014 BEVA Congress proceedings, and on the inside back cover of the 2014 Congress Planner. It contained the phrase “Neuraminidase antibodies provided a degree of protection in the case of HA strain/vaccine mismatch”, when viewed against the context of the advertisement headed ‘Why have part when you can have it all?”.
The Committee’s view was that the item in the context of the advertisement was intended to mean, and did convey, the meaning that the inclusion of NA antigens in an equine vaccine gave that vaccine a clinical advantage over vaccines which did not. This claim was not substantiated. Accordingly, the Committee found the phrase in breach of Code of Practice Clauses 4.1(iii) misleading, 4.1(vi) contained an exaggerated claim, 4.1(vii) implied it had a special merit which was not substantiated, 4.2(i) was not accurate and 4.2(ii) was not based upon an up-to-date evaluation of all the evidence.
Full details of the Committee’s rulings can be found on the NOAH website at www.noah.co.uk/code. The full report of this particular case will be available shortly.
The VetDebt Recovery Compass tool provides a way for practices to understand how outstanding payments affect their cash flow and practice value, and what steps to take next.
Mike Brooks, Chairman at DSL UK (pictured), said: “The VetDebt Recovery Compass offers a quick and easy way to see the true financial impact of unpaid debt.
"By making this information free and accessible to everyone, we hope to empower veterinary teams to take control of their finances.
DSL says that the new tool, which is available at www.dsluk.net, allows practices to see both the immediate recovery potential and the long-term value impact of their debts in less than 30 seconds.
The calculator also provides a species-specific breakdown, helping to identify where debt issues may be most significant and where to target first.
Mike has also appeared on the Federation of Independent Veterinary Practices (FIVP) Practice Matters Podcast, discussing how practices can better manage the topic of debt: https://fivp.org.uk/ep023-fivp-practice-matters-at-spvs-the-farm-vet-journey-practice-debt.
Andy Moores said: "Elbow replacement surgery, despite advancements in both the implant and technique, remains a complex procedure with a demanding rehabilitation process.
"However, for the right candidates, elbow replacement offers the potential for significant improvement in joint function and pain relief, transforming the lives of dogs that would otherwise suffer from permanent discomfort."
The third generation TATE elbow has had a complete redesign to overcome some of the issues associated with the first and second generation models, and the Iowa State system which preceded them.
There are around 15 surgeons qualified to perform the procedure in the world, three in the UK, and Andy is the only one in the South East.
Andy added: "The advancements in the TATE Elbow system represent a significant leap forward in veterinary orthopaedic surgery.
"End-stage elbow osteoarthritis is a horrible condition which can leave dogs in chronic pain and with no good treatment options.
"Being certified to perform third-generation TATE elbow replacements allows us to offer our patients the most advanced treatment options available, giving them the best chance for a pain-free, functional life."
www.mooresortho.com info@mooresortho.com
The talks will be free to join live on Zoom, while being simultaneously streamed into the Vet Mums Facebook group.
Following the live stream those on Zoom will be invited to join in a private, unrecorded QnA session.
Liz Barton, co-founder of WellVet and Vet Mums said: “We have spent the last year creating a fab new website for people to access some of the great content WellVet has created over the last few years.
"However, we also noticed a few challenges mentioned with increasing frequency and severity by Vet Mums members.
"It’s fantastic to bring together such great speakers to directly address these issues and provide advice and support to anyone affected.”
For more information, visit www.wellvet.co.uk.
The survey of 97 cat owners and 156 vets conducted in June last year found that currently only 30% of cat owners give supplements to their cat but 74% would be willing to try them.
The survey also found that whilst 80% of vets thought the main reasons to be hesitant about recommending feline supplements were palatability and the owner’s ability to give products, owners were less concerned about the ease of giving the supplement (53%), and more concerned about the cost (45%) and being unsure of the benefits (39%).
Tara Evans RVN, head of sales at Vita, said: “It is interesting that the majority of vets believe that practicalities around administering oral supplements is the main drawback to giving these products, whereas only 53% of owners were concerned about this.
"Understanding owner concerns regarding efficacy and price could help vets support more owners to move forward with supplements for their cats.”
According to the survey, the most frequently used supplements, by both vets and owners are those made to support joints.
Cat owners also showed an interest in giving supplements for general wellness (61%).
Tara added: “Owners are open to supplementing for general health, as well as more specific health-related issues.”
www.vitaanimalhealth.com
The first phase of research is being conducted this January and February 2023 and will analyse the amount and distribution of UK canine health research funding over the past decade.
Veterinary associations, societies and charities which support canine health research tend to identify funding priorities aligned with their own strategy and scope, taking account of independent peer review from experts in the field of research.
However, the RVC says that as there are many research funders working independently, some important research topics may be overlooked and separately funded projects can inadvertently overlap in their work.
This study endeavours to investigate these issues and consider how resources are prioritised across different areas of canine research.
Participating stakeholders will be asked their opinions on future research funding and this information will contribute to developing a long-term strategy for not-for-profit UK canine health research.
Thereafter, the aim is to create a pilot consultation process for developing a central prioritisation platform for future collaborative canine research.
The RVC’s says it has already got data and support from several major funders but is keen to maximise the scope of this research, so it is now looking for participation from specialist veterinary societies that fund research, and non-university organisations, such as charities, corporates or independent referral practices which conduct their own in-house canine research.
Dr Alison Skipper, Postdoctoral Researcher into Canine Research Funding within VetCompass at the RVC said: “We are really keen to hear from as many non-profit organisations involved with canine health research funding as possible. The breadth and depth of this data is vital to ensure that our findings accurately reflect this sector."
For more information about how to get involved, please visit https://rvc.uk.com/canine-research-funding-analysis.
The recall is for the following batches only:
Petlife is contacting retailers, veterinary surgeons and wholesale dealers to examine inventory immediately and quarantine products subject to this recall.
For further information, contact Dr J M Ballany on +44 1333 720257 or email: johnballany@btinternet.com.
Two recently published studies have demonstrated that the canine anti-emetic Cerenia® (maropitant - Pfizer) which was launched last year also relieves car sickness in dogs.
In a pilot study, 17 dogs were given either Cerenia or placebo one hour before being taken on a car journey. After a washout period of 10-14 days, each dog was crossed over to the other treatment and once again taken on a journey to assess travel sickness. The results showed that likelihood of vomiting was reduced by 70% when the dogs were given Cerenia compared to placebo – but due to the small number of dogs enrolled the results did not reach statistical significance.
The same research group also carried out a large, multicentre, blinded and placebo controlled study of Cerenia in preventing vomiting in 213 dogs known to be prone to travel sickness. They were given a single oral dose of Cerenia or placebo one hour before a car journey. The results showed that Cerenia was associated with a reduction in vomiting of 79% compared to placebo (p<0.0001).
The dosage of Cerenia used in both studies was 8mg/kg dose for the prevention of motion sickness–higher than the 2mg/kg dose that is routinely used to treat general emesis, administered at least one hour before the journey. According to the researchers’ report in the Veterinary Record, the need for a higher dose is linked to the specific neural (central) pathway of emetic stimulation that is involved in motion sickness. Cerenia acts primarily at NK1 receptors in the emetic centre and thus has the ability to block vomiting due to vestibular stimuli.
According to Pfizer, a single oral dose lasts for at least 12 hours, so pets can be dosed the night before an early start. For motion sickness prevention, Cerenia is licensed for up to 2 days’ consecutive use, so owners can use it for a return journey the next day if need be.
Pfizer also says that market research suggests almost one in five dogs suffers from travel sickness, which is not only inconvenient but does also stop some owners from travelling with their pet. In the past, owners have had to rely on OTC (over the counter) remedies or medicines developed for use in humans to prevent travel sickness. Many of these are ineffective or have unwanted effects such as sedation or extrapyramidial effects in dogs. Cerenia is the first anti-emetic to be developed specifically for use in dogs and was launched in April 2007– higher dose tablets aimed specifically for the prevention of travel sickness are expected to be made available early this year.
Figures produced by the Royal College of Veterinary Surgeons show that almost half of the first cohort of newly-qualified vets to sign up to the Professional Development Phase (PDP) have now completed it.
The PDP is a web-based database that enables new graduates to develop, and reflect on, their professional skills during their first year in clinical practice. Completing the PDP became a professional obligation for all newly-qualified vets from 2007 onwards. Of the 636 vets who graduated in 2007, 586 (92%) signed up to PDP and 290 have now completed. Of the 616 vets who graduated in 2008, 546 (88%) have so far registered for the PDP.
Freda Andrews, RCVS Head of Education, said: "Undertaking PDP is a professional requirement for every newly-qualified vet working in clinical practice. The first vets to undertake PDP seem to be taking around 15 months from signing up to signing off. Properly completing PDP counts as the first year's CPD and we strongly recommend that this year's graduates sign up as soon as they have found their first clinical role."
The PDP is also open to any vet returning to practice.
To find out more about PDP requirements, log onto www.rcvs.org.uk/pdp, to enrol, email pdp@rcvs.org.uk.
Edinburgh-based Braid Vets has signed up its 1000th client to the practice's VIP (Very Important Pet) Pet Health Plan.
To mark the event, staff at the practice and Kenneth Agnew from Practice Plan For Vets Ltd, presented 1000th member Douglas Roberts and his dog Rudy with a bottle of champagne and a Kong toy.
In common with other schemes, the Braid Vets Pet Health Plan spreads the costs of vaccinations and flea control over the year with a fixed monthly direct debit. In addition, Braid Vets gives its Health Plan members further discounts on selected services provided by the practice, including food purchases.
Mike Hall MRCVS of Braid Vets, said: "We think the Health Plan has been one of the things that has helped us withstand the worst effects of the recession. In our experience, Health Plan clients attend the clinic more regularly for health checks, vaccinations and treatments throughout the year."
He added: "We're delighted to have reached our 1000th member of the scheme, but we're not going to stop there. We think there's considerable scope for further growth. The reason is that it's such a no-brainer. Under our plan, vets have complete clinical freedom and always recommend the products best suited to the individual pet. So the pet wins, the client wins and the practice wins."
Anita Bates from Practice Plan for Vets, which manages this scheme and many others on behalf of veterinary practices in the UK, said: "Our health plans focus on preventative services and products. They provide the practice with a regular monthly income and bonded clients as well as improving owner compliance, frequency of visits to the practice and average transactions values for wellness and illness."
For more information about Practice Plan For Vets, visit: www.practiceplanforvets.co.uk
Vétoquinol has launched Flexadin, a new range of joint support products for cats and dogs with osteoarthritis (OA)
Robert Simpson, Flexadin Product Manager said: "This new range is made up of two products: Flexadin Plus and Flexadin Advanced, both are dietetic complementary feeds which are members of a small group of joint support products which contain Omega-3 fatty acids and Vitamin E. These ingredients are proven to aid the support of the metabolism of joints in the case of OA. Although many different joint support aids are available, not all of them contain these extra ingredients."
Vétoquinol says that in addition to Omega-3 fatty acids and Vitamin E, Flexadin Plus contains the traditional ingredients: glucosamine, chondroitin and devil's claw. Flexadin Advanced contains the novel ingredient, UCII - a type of undenatured type II collagen which has been manufactured using a patented process.
Flexadin Plus comes in two formulations, the first is specifically designed for cats/small dogs and the other is for medium/large dogs. Flexadin Advanced is specifically for dogs.
Robert added: "Flexadin Advanced has a specific property which means that the administration rate is only one chew per day whatever the weight of the dog. This has an important impact on the price per day for medium and large dogs which may require more than one tablet of traditional joint support products. This property also makes Flexadin Advanced a convenient option for owners. In addition to this benefit, UCII is becoming more and more popular due to the results of scientific studies in dogs, horses and even humans.
"We are all very excited about the advances this range can bring to veterinary practices."
Both Flexadin Plus and Advanced are presented as palatable, shaped, soft chews which come in zip-lock packs to keep the soft chews fresh and tasty. Flexadin Plus comes in packs of 90 chews whilst Flexadin Advanced comes in packs of 30 chews.
For further information about Flexadin, contact Vétoquinol on: 01280 825424.